Dr Reddys Laboratories (RDY) Short-term Investments: 2017-2025
- Dr Reddys Laboratories' Short-term Investments fell 43.27% to $506.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $506.0 million, marking a year-over-year decrease of 43.27%. This contributed to the annual value of $506.0 million for FY2025, which is 43.27% down from last year.
- As of Q1 2025, Dr Reddys Laboratories' Short-term Investments stood at $506.0 million, which was down 43.27% from $892.0 million recorded in Q1 2024.
- Over the past 5 years, Dr Reddys Laboratories' Short-term Investments peaked at $892.0 million during Q1 2024, and registered a low of $270.0 million during Q1 2021.
- Its 3-year average for Short-term Investments is $693.3 million, with a median of $682.0 million in 2023.
- Its Short-term Investments has fluctuated over the past 5 years, first spiked by 75.32% in 2023, then slumped by 43.27% in 2025.
- Quarterly analysis of 5 years shows Dr Reddys Laboratories' Short-term Investments stood at $270.0 million in 2021, then skyrocketed by 44.07% to $389.0 million in 2022, then surged by 75.32% to $682.0 million in 2023, then soared by 30.79% to $892.0 million in 2024, then plummeted by 43.27% to $506.0 million in 2025.
- Its last three reported values are $506.0 million in Q1 2025, $892.0 million for Q1 2024, and $682.0 million during Q1 2023.
